Delayed Hypersensitivity with Ferric CarboxymaltoseCorrespondence Address :
Dr. Ravindra Prabhu,
Professor and Head, Department of Nephrology, Kasturba Medical College, Manipal University, Manipal-576104, Karnataka, India.
Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of FCM. Here, we report a case of a 59-year-old male a known case of CKD, with anaemia and thrombocytopenia. FCM was the treatment of choice. This case report indicates the onset of adverse reaction with FCM with the second dose even though the first dose was well tolerated.
Anaemia, Hypersensitivity, Iron preparations
Surabhi Sridhara, Rajesh Vilakkathala, Ravindra Prabhu, Karan Saraf. DELAYED HYPERSENSITIVITY WITH FERRIC CARBOXYMALTOSE. Journal of Clinical and Diagnostic Research [serial online] 2017 November [cited: 2018 Jan 18 ]; 11:FD01-FD02. Available from
Date of Submission: Dec 09, 2016
Date of Peer Review: Jan 24, 2017
Date of Acceptance: Oct 12, 2017
Date of Publishing: Nov 01, 2017
FINANCIAL OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2016: 132.37
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase & EMbiology
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)